BRIDGEWAY CAPITAL MANAGEMENT, LLC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 37 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2019$42,000
-55.8%
202,5880.0%0.00%0.0%
Q2 2019$95,000
+6.7%
202,5880.0%0.00%0.0%
Q1 2019$89,000
+41.3%
202,5880.0%0.00%0.0%
Q4 2018$63,000
-57.1%
202,5880.0%0.00%0.0%
Q3 2018$147,000
+69.0%
202,5880.0%0.00%0.0%
Q2 2018$87,000
-46.6%
202,588
-33.0%
0.00%
-50.0%
Q1 2018$163,000
-18.5%
302,5880.0%0.00%0.0%
Q4 2017$200,000
+13.6%
302,5880.0%0.00%0.0%
Q3 2017$176,000
-30.4%
302,5880.0%0.00%
-33.3%
Q2 2017$253,000
-38.6%
302,5880.0%0.00%
-40.0%
Q1 2017$412,000
+205.2%
302,5880.0%0.01%
+150.0%
Q4 2016$135,000
-20.1%
302,5880.0%0.00%
-33.3%
Q3 2016$169,000
-12.9%
302,5880.0%0.00%0.0%
Q2 2016$194,000
-34.0%
302,588
-13.4%
0.00%
-40.0%
Q1 2016$294,000
-17.6%
349,5460.0%0.01%
-28.6%
Q4 2015$357,000
-13.3%
349,5460.0%0.01%
-22.2%
Q3 2015$412,000
-35.4%
349,546
+6.8%
0.01%
-30.8%
Q2 2015$638,000
+19.3%
327,344
+8.8%
0.01%
+18.2%
Q1 2015$535,000
+16.8%
300,826
+20.9%
0.01%
+10.0%
Q4 2014$458,000
-5.4%
248,810
+24.4%
0.01%
-16.7%
Q3 2014$484,000200,0000.01%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Camber Capital Management LP 13,275,000$8,496,0000.41%
Broadfin Capital, LLC 2,025,268$1,296,0000.13%
Baillie Gifford 6,361,364$4,071,0000.01%
Spark Investment Management LLC 73,200$46,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 302,588$194,0000.00%
WEDBUSH SECURITIES INC 18,000$12,0000.00%
Financial Architects, Inc 10,000$6,0000.00%
Psagot Value Holdings Ltd. 22,050$14,0000.00%
BARCLAYS PLC 629,591$403,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 800,900$513,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders